A prospective evaluation of the biochemical, metabolic, hormonal and structural bone changes associated with bortezomib response in multiple myeloma patients

We prospectively evaluated the bone changes associated with proteasome inhibition using single agent bortezomib in relapsed or refractory myeloma patients. Ten patients received bortezomib 1.3 mg/m(2) per days 1, 4, 8 and 11 for three 21-day cycles, and 6 patients received 1 mg/m(2) per day with the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zangari, Maurizio, Yaccoby, Shmuel, Pappas, Lisa, Cavallo, Federica, Kumar, Naveen Sanath, Ranganathan, Subramanian, Suva, Larry J., Gruenwald, J. Michael, Kern, Steven, Zhan, Fenghuang, Esseltine, Dixie, Tricot, Guido
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2011
Assuntos:
Brief Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3031705/
https://ncbi.nlm.nih.gov/pubmed/20952514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2010.031302
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados